» Authors » Mark Stern

Mark Stern

Explore the profile of Mark Stern including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 9
Citations 100
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Tounekti O, Prior S, Wassmer S, Xu J, Wong A, Fang X, et al.
Bioanalysis . 2025 Jan; 17(3):105-149. PMID: 39862111
The 18 Workshop on Recent Issues in Bioanalysis (18 WRIB) took place in San Antonio, TX, USA on May 6-10, 2024. Over 1100 professionals representing pharma/biotech companies, CROs, and multiple...
2.
Werth V, Merrill J, Furie R, Dorner T, van Vollenhoven R, Lipsky P, et al.
J Am Acad Dermatol . 2024 Oct; 92(3):435-443. PMID: 39461504
Background: Iberdomide, a cereblon modulator, promotes degradation of transcription factors Ikaros and Aiolos. Objective: Evaluate iberdomide efficacy and safety in cutaneous lupus erythematosus (CLE) in a phase 2 study. Methods:...
3.
Hernandez K, Bramlett K, Agius P, Baden J, Cao R, Clement O, et al.
J Mol Diagn . 2023 Feb; 25(3):143-155. PMID: 36828596
The Blood Profiling Atlas in Cancer (BLOODPAC) Consortium is a collaborative effort involving stakeholders from the public, industry, academia, and regulatory agencies focused on developing shared best practices on liquid...
4.
Stern M, Finch A, Haskard-Zolnierek K, Howard K, Deason R
J Health Psychol . 2022 Jul; 28(4):388-401. PMID: 35811484
This study assessed specific cognitive impairments within a primarily female, hypothyroid population, while controlling for factors that commonly contribute to cognitive decline. Participants ( = 739) included 461 individuals with...
5.
Lipsky P, van Vollenhoven R, Dorner T, Werth V, Merrill J, Furie R, et al.
Ann Rheum Dis . 2022 Apr; 81(8):1136-1142. PMID: 35477518
Objectives: Iberdomide is a high-affinity cereblon ligand that promotes proteasomal degradation of transcription factors Ikaros () and Aiolos (). Pharmacodynamics and pharmacokinetics of oral iberdomide were evaluated in a phase...
6.
Uwadiale A, Cordaro M, Brunett K, Stern M, Howard K
Issues Ment Health Nurs . 2021 Sep; 43(3):272-281. PMID: 34529543
A nationwide survey assessed the prevalence and pandemic-related risk factors of major depressive disorder (MDD) at the initial onset of the COVID-19 pandemic. Findings showed a significant increase in the...
7.
Qi Z, Wang L, Desai K, Cogswell J, Stern M, Lawson B, et al.
J Mol Diagn . 2019 Jul; 21(5):796-807. PMID: 31255795
Clinical biomarker studies are often hindered by the scarcity or suboptimal quality of biological specimens. EdgeSeq, a transcriptomics analysis platform, combines quantitative nuclease protection assay technology with next-generation sequencing, using...
8.
Georgy M, Stern M, Murphy K
Can Assoc Radiol J . 2017 Oct; 68(4):419-424. PMID: 28985974
This review presents a summary of the pathology and epidemiology of Modic changes and the possible role of Propionibacterium acnes. This information is followed by a synthesis of the most...
9.
Stephan R, Alhassoon O, Allen K, Wollman S, Hall M, Thomas W, et al.
Am J Drug Alcohol Abuse . 2016 Oct; 43(1):24-43. PMID: 27712350
Background: Promising models for cognitive rehabilitation in alcohol treatment rest on a more nuanced understanding of the associated impairments in the multifaceted domains of executive functioning (EF) and impulsivity. Objectives:...
10.
Padmanabhan A, Stern M, Wishin J, Mangino M, Richey K, DeSane M
Am J Crit Care . 2007 Jun; 16(4):384-93. PMID: 17595371
Background: Management of fecal incontinence is a priority in acute and critical care to reduce risk of perineal dermatitis and transmission of nosocomial infections. Objective: To evaluate the safety of...